Fund Holdings — Propel Bio Management, LLC

Total Portfolio Value:
$172.41M
Total Bought:
$5.33M
Total Sold:
$13.74M
Net Transaction:
-$8.41M
Notable People:
Leen Kawas, James Francis Harding
Securities
▲▼
SharesValue
Q2 2024
▲▼
Q3 2024
▲▼
Change
▲▼
Q2 2024
▲▼
Q3 2024
▲▼
Weight (%)
▲▼
Change
▲▼
Applied Therapeutics IncCOMM6,567,8586,567,8580$30.67M$55.83M32.38%+$25.15M
Plains GP Holdings, L.P.COMM(PAGP)1,372,3601,272,360-100,000$25.83M$23.54M13.65%-$2.29M
Phathom Pharmaceuticals, Inc.COMM(PHAT)869,927869,9270$8.96M$15.73M9.12%+$6.77M
Achieve Life Sciences IncCOMM2,453,0922,453,0920$11.53M$11.63M6.74%+$98.1K
TScan Therapeutics, Inc.COMM(TCRX)2,087,1392,087,1390$12.21M$10.39M6.03%-$1.82M
Akero Therapeutics IncCOMM327,752343,729+15,977$7.69M$9.86M5.72%+$2.17M
Madrigal Pharmaceuticals, Inc.COMM(MDGL)43,03243,0320$12.06M$9.13M5.30%-$2.92M
Avidity Biosciences IncCOMM178,500178,5000$7.29M$8.20M4.76%+$906.8K
Ardelyx IncCOMM924,5831,070,947+146,364$6.85M$7.38M4.28%+$527.7K
Telesat CorporationCOMM(TSAT)365,781365,7810$3.33M$4.82M2.79%+$1.49M
Abeona Therapeutics Inc.COMM(ABEO)1,248,044624,022-624,022$5.29M$3.94M2.29%-$1.35M
Kymera Therapeutics, Inc.COMM(KYMR)56,35956,3590$1.68M$2.67M1.55%+$985.2K
Syndax Pharmaceuticals, Inc.COMM(SNDX)83,259133,259+50,000$1.71M$2.57M1.49%+$855.9K
Kura Oncology, Inc.COMM(KURA)130,000130,0000$2.68M$2.54M1.47%-$136.5K
Zevra Therapeutics, Inc.COMM(ZVRA)0179,874+179,874$0$1.25M0.72%+$1.25M
Eiger BiopharmaceuticalsCOMM146,381146,3810$1.85M$1.24M0.72%-$607.5K
Athira Pharma IncCOMM1,492,7921,492,7920$3.96M$665.8K0.39%-$3.29M
COMPASS Pathways plcCOMM(CMPS)080,000+80,000$0$504.0K0.29%+$504.0K
Verrica Pharmaceuticals Inc.COMM(VRCA)424,937344,937-80,000$3.10M$500.2K0.29%-$2.60M
Maat Pharma SacaCOMM02,397+2,397$0$17.8K0.01%+$17.8K
Chinook TherapeuticsCOMM79,35779,3570$9.8K$9.8K0.01%$0
Cybin D/B/A Helus PharmaCOMM(HELP)850,0000-850,000$230.3K$0—-$230.3K
Fulcrum Therapeutics, Inc.COMM(FULC)750,0000-750,000$4.65M$0—-$4.65M
Trevi Therapeutics, Inc.COMM(TRVI)260,0000-260,000$774.8K$0—-$774.8K
Maat Pharma SacaCOMM1,3620-1,362$9.8K$0—-$9.8K
Kayne Anderson Energy Infrastructure Fund, Inc.COMM(KYN)147,0330-147,033$1.52M$0—-$1.52M
Fidelity Inv Mmtrsy 1 680COMM317,0140-317,014$317.0K$0—-$317.0K
Page 1 of 1
Propel Bio Management, LLC — 13F Holdings — Q3 2024 | TickerTrail